Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Passage Bio, Inc. - Common Stock
(NQ:
PASG
)
18.46
+2.35 (+14.59%)
Streaming Delayed Price
Updated: 4:00 PM EST, Jan 6, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Passage Bio, Inc. - Common Stock
< Previous
1
2
3
4
5
6
Next >
Passage Bio to Present at Chardan’s 8th Annual Genetic Medicines Conference
September 23, 2024
From
Passage Bio
Via
GlobeNewswire
Passage Bio to Present Positive Interim Data from Cohort 1 Patients with FTD-GRN in upliFT-D Study at 14th International Conference on Frontotemporal Dementias (ISFTD2024)
September 16, 2024
From
Passage Bio
Via
GlobeNewswire
Passage Bio Welcomes Tom Kassberg to Board of Directors
September 10, 2024
From
Passage Bio
Via
GlobeNewswire
12 Health Care Stocks Moving In Monday's After-Market Session
↗
September 02, 2024
Via
Benzinga
Passage Bio to Present at H.C. Wainwright 26th Annual Global Investment Conference
August 30, 2024
From
Passage Bio
Via
GlobeNewswire
PASG Stock Earnings: Passage Bio Beats EPS for Q2 2024
↗
August 08, 2024
PASG stock results show that Passage Bio beat analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
Passage Bio Reports Second Quarter 2024 Financial Results and Provides Recent Business Highlights
August 08, 2024
From
Passage Bio
Via
GlobeNewswire
Passage Bio to Participate in Upcoming Investor Conferences
August 06, 2024
From
Passage Bio
Via
GlobeNewswire
Passage Bio Out-licenses Three Pediatric Gene Therapy Programs to GEMMA Biotherapeutics and Enters New Research Collaboration
August 01, 2024
From
Passage Bio
Via
GlobeNewswire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
↗
July 16, 2024
It's time to dive into the biggest pre-market stock movers as we check out all of the latest news worth reading about on Tuesday morning!
Via
InvestorPlace
Passage Bio Announces Positive Feedback from FDA on Expansion of upliFT-D Trial of PBFT02 to Include FTD-C9orf72 Patients
July 16, 2024
From
Passage Bio
Via
GlobeNewswire
Passage Bio to Present at Goldman Sachs 45th Annual Global Healthcare Conference
June 05, 2024
From
Passage Bio
Via
GlobeNewswire
PASG Stock Earnings: Passage Bio Beats EPS for Q1 2024
↗
May 14, 2024
PASG stock results show that Passage Bio beat analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
Passage Bio Reports First Quarter 2024 Financial Results and Provides Recent Business Highlights
May 14, 2024
From
Passage Bio
Via
GlobeNewswire
Passage Bio to Present at Chardan’s 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit
April 22, 2024
From
Passage Bio
Via
GlobeNewswire
PASG Stock Earnings: Passage Bio Beats EPS for Q4 2023
↗
March 06, 2024
PASG stock results show that Passage Bio beat analyst estimates for earnings per share the fourth quarter of 2023.
Via
InvestorPlace
Passage Bio Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Recent Business Highlights
March 04, 2024
From
Passage Bio
Via
GlobeNewswire
Passage Bio to Participate in Upcoming Investor Conferences
February 27, 2024
From
Passage Bio
Via
GlobeNewswire
7 Analyst-Backed Stocks With Promising 10-Bagger Potential
↗
February 01, 2024
Although true 10-baggers are by nature extremely difficult to come by, these analyst-backed stocks may offer a decent shot.
Via
InvestorPlace
Passage Bio to Present at Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
January 31, 2024
From
Passage Bio
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's Pre-Market Session
↗
January 26, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
↗
January 22, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
↗
January 17, 2024
Via
Benzinga
7 Nano-Cap Stocks That Pack a Serious Punch for Their Weight
↗
December 25, 2023
Although nano-cap stocks are super-risky just like stealing bases in baseball, there may be a time and place for extreme speculation.
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
December 21, 2023
Via
Benzinga
Why BlackBerry Shares Are Trading Lower By Over 5%; Here Are 20 Stocks Moving Premarket
↗
December 21, 2023
Shares of BlackBerry Limited (NYSE: BB) moved lower in pre-market trading following the release of third-quarter results.
Via
Benzinga
Neurology-Focused Passage Bio Reveals Initial Data From Dementia Study, Outlines Strategic Priorities
↗
December 20, 2023
Passage Bio Inc (NASDAQ: PASG) announced initial safety and biomarker data from three Cohort 1 patients in the ongoing global Phase 1/2 upliFT-D clinical trial evaluating PBFT02, an adeno-associated...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
December 20, 2023
Via
Benzinga
Passage Bio Announces Promising Initial Data From Phase 1/2 Clinical Trial of PBFT02 in FTD-GRN and Updated Strategic Priorities
December 20, 2023
From
Passage Bio
Via
GlobeNewswire
Passage Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
November 17, 2023
From
Passage Bio
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
